ULTRAPEN LA 300 mg/ml, injekcinė suspensija
ULTRAPEN LA 300 mg/ml, injekcinė suspensija
Not authorised
- BENZYLPENICILLIN PROCAINE
Product identification
Medicine name:
ULTRAPEN LA 300 mg/ml, injekcinė suspensija
Active substance:
- BENZYLPENICILLIN PROCAINE
Target species:
-
Cattle
-
Pig
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
BENZYLPENICILLIN PROCAINE300.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal21day
-
Milk5day
-
-
Pig
-
Meat and offal7day
-
-
-
Subcutaneous use
-
Cattle
-
Meat and offal10daySubcutaneous use for non-lactating cattle.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CE09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Surrendered
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Manufacturing Limited
- Norbrook Laboratories Limited
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/00/1153/001-002
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV1153.pdf
Lithuanian (PDF)
Download Published on: 30/06/2022